What You Need to Know About Puma Biotech's 25% Slide

By: via Benzinga
Shares of Puma Biotechnology Inc (NASDAQ: PBYI), a development stage biotech company focusing on cancer treatment, are down over 25 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.